Structural Requirements for Major Histocompatibility Complex Class II Invariant Chain Endocytosis and Lysosomal Targeting*

Sunghyun KangDagger , Liang LiangDagger , Cynthia D. Parker, and James F. Collawn§

From the Department of Cell Biology, University of Alabama at Birmingham, Birmingham, Alabama 35294-0005

    ABSTRACT
Top
Abstract
Introduction
Procedures
Results
Discussion
References

The invariant chain (Ii) targets newly synthesized major histocompatibility complex class II complexes to a lysosome-like compartment. Previously, we demonstrated that both the cytoplasmic tail (CT) and transmembrane (TM) domains of Ii were sufficient for this targeting and that the CT contains two di-leucine signals, 3DQRDLI8 and 12EQLPML17 (Odorizzi, C. G., Trowbridge, I. S., Xue, L., Hopkins, C. R., Davis, C. D., and Collawn, J. F. (1994) J. Cell Biol. 126, 317-330). In the present study, we examined the relationship between signals required for endocytosis and those required for lysosomal targeting by analyzing Ii-transferrin receptor chimeras in quantitative transport assays. Analysis of the Ii CT signals indicates that although 3DQRDLI8 is necessary and sufficient for endocytosis, either di-leucine signal is sufficient for lysosomal targeting. Deletions between the two signals reduced endocytosis without affecting lysosomal targeting. Transplantation of the DQRDLI sequence in place of the EQLPML signal produced a chimera that trafficked normally, suggesting that this di-leucine sequence coded for an independent structural motif. Structure-function analysis of the Ii TM region showed that when Ii TM residues 11-19 and 20-29 were individually substituted for the corresponding regions in the wild-type transferrin receptor, lysosomal targeting was dramatically enhanced, whereas endocytosis remained unchanged. Our results therefore demonstrate that the structural requirements for Ii endocytosis and lysosomal targeting are different.

    INTRODUCTION
Top
Abstract
Introduction
Procedures
Results
Discussion
References

Major histocompatibility complex class II molecules are cell surface molecules that function to bind peptide antigens and present them to CD4+ helper T cells. Newly synthesized major histocompatibility complex class II alpha beta complexes are targeted to lysosome-like compartments (1-3) by the invariant chain (Ii)1 (reviewed in Ref. 4). Upon arrival, Ii is degraded, and alpha beta chains acquire peptide antigens (5-11). alpha beta Ii complexes are delivered to the lysosomal compartment from the TGN directly (11) or indirectly from the cell surface, where they are rapidly endocytosed (6, 12, 13). Both direct and indirect pathways are utilized for delivery of class II to a processing compartment (6, 11, 13, 14).

Support for the idea that Ii is sorted to the latter stages of the endocytic pathway comes from studies in which the Ii cytoplasmic tail was replaced with the TR cytoplasmic tail (15). Newly synthesized class II molecules containing this TR-Ii chimera are delivered to the cell surface and efficiently internalized, but Ii proteolysis is blocked, and class II antigen presentation is inhibited (15). This suggests that the TR cytoplasmic tail, which contains a tyrosine-based internalization signal (16, 17), is not sufficient for delivery of the class II complexes to a lysosome-like processing compartment and that additional sorting information is required.

Two Ii cytoplasmic tail targeting signals have been identified using Ii-neuraminidase chimeras (18) and Ii-TR chimeras (14), Leu7-Ile8 and Met16-Leu17. These di-leucine signals were first identified in the CD3 gamma -chain and the cation-dependent mannose 6-phosphate receptor and shown to be important for lysosomal and late endosomal targeting, respectively (19, 20). They consist of two hydrophobic residues, usually leucine-leucine or leucine-isoleucine, that are often preceded by four hydrophilic residues (19). For Ii, residues amino-terminal to the di-leucine-like motifs are important for sorting (14, 21, 22), suggesting that Ii di-leucine signals like those found in the CD3 gamma - and delta -chains consist of six residues, 3DQRDLI8 and 12EQLPML17.

NMR structural data on the Ii cytoplasmic tail suggests that the membrane-distal signal lies within a nascent helix, whereas the membrane-proximal motif is a part of a turn (22). Tyrosine-based signals have been proposed to be turn structures as well (16, 23-25), and have been shown to form independent structural motifs because one tyrosine-based signal can often substitute for another (26-28). Whether di-leucine-based signals form independent structural motifs is unknown. Furthermore, how tyrosine- and di-leucine-based signals are related is unclear, especially because they appear to be recognized by distinct cytosolic factors (29).

Athough native Ii is a trimer, studies of mixed trimers containing wild-type and tailless Ii demonstrate that trimers containing at least two wild-type Ii molecules are targeted properly in fibroblasts (30), illustrating that molecules containing two or three Ii cytoplasmic tails traffic the same. Furthermore, the quaternary structural requirements for Ii sorting appear to be flexible because tetramers containing the Ii cytoplasmic tail spliced to the transmembrane and extracellular domains of neuraminidase traffic the same as wild-type Ii trimers (18).

The purpose of this study was to define how internalization signals differ from those required for delivery to the latter stages of the endocytic pathway. We examined two regions of the Ii that had previously been shown to be important for targeting to the lysosomal compartment, the cytoplasmic tail (CT) and the transmembrane region (TM) (14). We took advantage of the fact that we could quantitatively monitor 1) internalization using radiolabeled transferrin (Tf), and 2) lysosomal targeting by monitoring the half-lives of the Ii-TR chimeras (14). Mutational and functional analysis of Ii CT suggests that some mutations affected endocytosis, some affected lysosomal targeting, and some affected both. Analysis of the Ii TM region indicated that two distinct regions within the TM were sufficient to confer lysosomal targeting on a reporter molecule without affecting internalization rates. The results demonstrate that the structural requirements for Ii endocytosis and lysosomal targeting are not the same.

    EXPERIMENTAL PROCEDURES
Top
Abstract
Introduction
Procedures
Results
Discussion
References

Human Ii-TR Constructs-- Mutants were prepared as described previously (14) by the method of Kunkel (31). Polymerase chain reaction fragments encoding the various cytoplasmic tail deletion mutants were subcloned into a tailless TR construct that contained BglII and NheI sites 5' to the start site and at the beginning of the transmembrane region (amino acid position 64-65 in the TR sequence), respectively (CCL-1). Introduction of the NheI site created a substitution mutation (Ala for Gly at position 64, GGA-AGT right-arrow GCT-AGC). This substitution had no effect on internalization or expression levels. Mutants were screened and selected by restriction mapping or sequencing and cloned into the expression vector BH-RCAS (32). All mutations were verified by dideoxynucleotide sequencing of the entire cytoplasmic or transmembrane domain in BH-RCAS constructs (33, 34).

Expression of Ii Chimeras and Wild-type TR-- Ii chimeras and wild-type TR were expressed in chicken embryo fibroblasts (CEFs) as described previously (35). Surface expression of Ii chimeras and mutants was determined by measuring the binding of 125I-labeled Tf at 4 °C (35).

Internalization Assay-- The rate of Tf internalization was determined using the IN/SUR method (36). Diferric human Tf (Miles Scientific, Naperville, IL) was labeled with 125I to a specific activity of 2-4 µCi/µg using Enzymobeads (Bio-Rad) according to the manufacturer's directions. CEFs were plated in triplicate at a density of 7.5 × 104 cells/cm2 in 24-well tissue culture plates 24 h before the assay (Costar Corp., Cambridge, MA). Cells were incubated in serum-free Dulbecco's modified Eagle's medium for 1 h at 37 °C. Prewarmed (37 °C) 125I-labeled Tf (4 µg/ml) in 0.15 ml of 0.15 M NaCl, 0.01 M sodium phosphate buffer (pH 7.4) containing 0.1% bovine serum albumin (BSA-PBS) was added to each well. After incubation for 0, 2, 4, 6 or 8 min, the incubation medium was removed, and the cells were placed on ice and rinsed with ice cold BSA-PBS three times. The cells were then incubated twice for 3 min with 0.5 ml of 0.2 M acetic acid-0.5 M sodium chloride (pH 2.4) to remove surface bound 125I-labeled Tf (37). Cells were then lysed with 1 M NaOH. Radioactivity in the acid wash (SUR) and in the cell lysate (IN) was determined. The ratio of internalized (IN) to surface (SUR) ligand (IN/SUR) yields a biphasic curve when plotted as a function of time (36). The slope was calculated by linear regression to determine the endocytic rate constant ke.

Measurement of Proteolysis after Internalization-- Measurement of 125I-labeled Tf was determined as described previously (14).

Metabolic Labeling and Immunoprecipitation-- Metabolic labeling of CEFs expressing the various Ii chimeras and immunoprecipitation of the Ii chimeras were performed as described previously (14).

Calculation of the Surface-accessible Counts-- To estimate the relative amount of chimera that is delivered to the cell surface, we used the following calculation: Surface-accessible pool (%) = (Surface-labeled countschimera/Surface-labeled countsTR) × (Relative biosynthetic rateTR/Relative biosynthetic ratechimera) × (Half-lifeTR/Half-lifechimera) × 100.

To determine the surface-labeled counts, we incubated cells with 125I-labeled Tf for 1 h to label the endocytic pathway. The cells were then washed with BSA-PBS at 4 °C to remove the unbound Tf, lysed in 1% Nonidet P-40, and counted in a gamma counter. Comparison between the individual cell lines gave an estimate of the total amount of chimeras on the surface and in endosomal compartments (surface-labeled counts). To determine the relative biosynthetic rate, we pulsed cells with 35S-trans label for 30 min. The relative biosynthetic rate refers to the relative protein expression of each of the constructs compared with the wild-type TR. TR or Ii-TR chimeras were then immunoprecipitated from postnuclear supernatants and quantitated on SDS-polyacrylamide gels by PhosphorImager analysis. To determine the relative degradation rate, we measured the relative half-lives of each of the constructs using a metabolic pulse-chase procedure. The relative biosynthetic and degradation rates were then compared with the wild-type TR control.

For example, if the surface-labeled counts of the chimera are 25% that of the TR, the relative biosynthetic rate is 4 times that of the TR, and the relative degradation rate is 8 times (t1/2 chimera = 3 h; t1/2 TR = 24 h), then the percentage of the chimeras reaching the cell surface (surface-accessible pool) is 50% (1/4 × 1/4 × <FR><NU>24</NU><DE>3</DE></FR> × 100%). In this case, 50% of the chimeras traffic directly to the lysosome, and 50% are delivered to the cell surface before delivery to the lysosome. This calculation assumes that all of the TR that is synthesized reaches the cell surface and that little degradation of the chimeras occurs during the 1 h of labeling (125I-labeled Tf) from the surface (surface-labeled counts).

    RESULTS
Top
Abstract
Introduction
Procedures
Results
Discussion
References

Ii-TR Chimeras Are Expressed on the Cell Surface and Rapidly Internalized-- To determine whether the structural features of Ii that are important for endocytosis are the same as those required for targeting to the latter stages of the endocytic pathway, we constructed Ii-TR chimeras consisting of either the wild-type or mutant Ii cytoplasmic tails spliced to the transmembrane and extracellular domains of TR (Fig. 1). Wild-type human TR and Ii-TR chimeras were stably expressed in CEFs using BH-RCAS, a replication-competent retroviral vector derived from the Rous sarcoma virus (38). Binding studies at 4 °C using 125I-labeled human Tf indicated that all of the Ii-TR chimeras were expressed on the cell surface, although at lower levels than the wild-type TR (data not shown).


View larger version (28K):
[in this window]
[in a new window]
 
Fig. 1.   Cytoplasmic tail and transmembrane sequences of the TR, Ii, and Ii-TR chimeras. A, schematic diagram of wild-type (WT) TR, TR Delta 2-59, and WT Ii molecules. The amino acid sequences of the cytoplasmic tails and transmembrane regions of each are shown. B, schematic diagram of Ii-TR chimera and cytoplasmic tail sequences of mutant Ii-TR chimeras. Unshaded areas represent regions of Ii-TR derived from TR; shaded areas represent regions derived from Ii. EC, extracellular domain. Constructs are referred to in text by the corresponding names shown at the left.

Internalization rates of the Ii-TR chimeras were monitored using the IN/SUR method of Wiley and Cunningham (36). Analysis of the chimera with the wild-type Ii chain cytoplasmic tail (IiCT) indicated that it was internalized as rapidly (ke = 0.117 min-1) as the wild-type TR (ke = 0.107 min-1; Table I). This internalization rate compares favorably with human TR internalization rates determined in other cell types (25). A tailless TR (Delta 2-59), for comparison, was internalized poorly (ke = 0.006 min-1; Table I).

                              
View this table:
[in this window]
[in a new window]
 
Table I
Comparisons of the internalization rates of the invariant chain cytoplasmic tail mutants

Residues 20-29 of the Ii Cytoplasmic Tail Are Not Required for Endocytosis or Lysosomal Targeting-- Two regions of the Ii chain cytoplasmic tail, residues 3-8 and 12-17, have been reported to be important for sorting in the endocytic pathway (14, 18, 21, 22, 39). Additional signals may be contained in the membrane-proximal region of the Ii cytoplasmic tail (15, 40). To determine whether the first 19 residues of the Ii chain cytoplasmic tail were sufficient for both endocytosis and lysosomal targeting, we prepared three deletion mutants, IiCT Delta 20-29, IiCT Delta 20-24, and IiCT Delta 25-29 (Fig. 1B). Each deletion mutant was tested in internalization assays and found to have nearly wild-type internalization activity (74-120%; Table I), indicating that residues 20-29 were not required.

Because Ii is transported to an acidic endocytic compartment, where it is rapidly degraded (5-8), we next determined the effect of these deletions on the half-lives of the chimeras in metabolic pulse-chase experiments. CEFs expressing either TR, IiCT, Ii CT Delta 20-29, Ii CT Delta 20-24, or the Ii CT Delta 25-29 mutant were pulse-labeled with 35S-trans label for 30 min and chased in complete medium for the indicated periods of time; TR and Ii-TR chimeras were then isolated by immunoprecipitation and analyzed by SDS-PAGE (Fig. 2). The IiCT chimera was rapidly degraded with an average half-life of 3.1 ± 0.4 h (Table II, average ± S.E.), similar to the half-life of native Ii in antigen presenting cells (41), whereas the Ii CT Delta 20-29 chimera was degraded with a half-life of 6.7 ± 0.2 h (Table II, average ± S.E.). Interestingly, the Ii-TR chimeras with smaller deletions were degraded more rapidly (IiCTDelta 20-24, t1/2 ~3.0 ± 0.1 h; IiCTDelta 25-29, t1/2 ~3.7 ± 0.9 h), suggesting that none of the residues from 20 to 29 per se were important for targeting to the processing compartment. In contrast, the half-life of the wild-type TR was greater than 20 h (t1/2 = 21.2 ± 1.6 h, Table II). After 2 h (Fig. 2), the Mr of TR and Ii-TR chimeras increased to that of the mature glycoprotein (42), indicating that the Ii-TR chimeras traverse the Golgi where glycosylation is complete and are degraded in a post-Golgi compartment. Degradation of the IiCT chimera occurred within the endocytic pathway because treatment of the cells with 50 mM NH4Cl during the labeling and chase period increased the half-life dramatically (data not shown).


View larger version (32K):
[in this window]
[in a new window]
 
Fig. 2.   Residues 20-29 of the invariant chain cytoplasmic tail are not required for efficient lysosomal targeting. Equivalent cell numbers of CEFs expressing wild-type TR, IiCT, IiCTDelta 20-29, IiCT20-24, or IiCT25-25 chimeras were pulse-labeled for 30 min with 35S-trans label and chased with complete medium for various periods of time as indicated (in hours). Wild-type TR or IiCT chimeras were then immunoprecipitated from postnuclear supernatants and analyzed on SDS-polyacrylamide gels as described under "Experimental Procedures." Dried gels were exposed to XAR film overnight (Kodak). Immunoprecipitates were quantitated on a Model 425 PhosphorImager (Molecular Dynamics). A representative experiment (of three) is shown.

                              
View this table:
[in this window]
[in a new window]
 
Table II
Comparisons of the half-lives of the invariant chain-transferrin receptor chimeras

The Membrane-distal Signal, DQRDLI, Is Necessary for Endocytosis and Sufficient for Lysosomal Targeting-- Two di-leucine-like signals, Leu7-Ile8 and Met16-Leu17, are reported to promote Ii internalization (14, 18). These studies, however, relied on radiolabeled bivalent antibody uptake (18) or steady-state distributions (14) to monitor endocytosis. To monitor internalization rates more precisely, we measured 125I-labeled Tf uptake for the IiCT Ala7-Ala8 mutant and the IiCT Ala16-Ala17 mutant (Fig. 1B). Comparison of the internalization rates indicated that IiCT Ala7-Ala8 mutant was internalized poorly (ke = 0.013), whereas the IiCT Ala16-Ala17 mutant had significant activity (ke = 0.066) (Fig. 3, A versus B). The IiCT Ala16-Ala17 mutant had 65% activity (IiCT ke = 0.101, Fig. 3B), whereas the IiCT Ala7-Ala8 mutant had ~13% activity, similar to the background activity of a tailless TR (~8% activity, ke = 0.008, Fig. 3C). The IiCT mutant was internalized at essentially the same rate as the wild-type TR (Fig. 3B, ke = 0.101 versus 0.114, respectively). The results indicate that the membrane-distal signal, Leu7-Ile8, is required for efficient endocytosis, whereas the membrane-proximal signal, Met16-Leu17, is not.


View larger version (18K):
[in this window]
[in a new window]
 
Fig. 3.   Comparisons of the internalization rates of Ii-TR chimeras containing various cytoplasmic tail mutations. CEFs expressing the various Ii-TR chimeras were incubated with prewarmed (37 °C) 125I-labeled Tf for the indicated times. The amounts of internalized (Internal Tf) and surface-associated (Surface Tf) radiolabel were determined as described under "Experimental Procedures." Data are plotted using the IN/SUR method, in which the slope of the line equals the endocytic rate constant ke (36). Three representative experiments are shown.

We next determined the effect of the Ala7-Ala8 and Ala16-Ala17 mutations on lysosomal targeting by analyzing these chimeras in metabolic pulse-chase experiments. The results indicate that both chimeras were rapidly degraded (t1/2 ~ 5.2 h (Fig. 4A) and t1/2 ~ 7.0 h (Fig. 4B), respectively), although neither was degraded as rapidly as the wild-type Ii chimera (average = 3.1 h, Table II). This demonstrated that either region was sufficient for lysosomal targeting.


View larger version (44K):
[in this window]
[in a new window]
 
Fig. 4.   IiCT Ala7-Ala8 and IiCT Ala16-Ala17 chimeras are rapidly degraded in a post-Golgi compartment. Equivalent cell numbers of CEFs expressing wild-type TR or IiCT Ala7-Ala8 chimeras (A) or wild-type TR, IiCT, or IiCT Ala16-Ala17 chimeras (B) were pulse-chased, immunoprecipitated from postnuclear supernatants, and analyzed as described in Fig. 2. Representative experiments (of three) are shown.

To determine whether the cell surface pool of IiCT Ala7-Ala8 chimeras was delivered to the lysosomal compartment despite its poor internalization activity, we incubated cells expressing IiCT Ala7-Ala8 IiCT, or wild-type TR with 125I-labeled Tf for 1 h at 37 °C. This procedure loaded the endocytic pathway with receptor-ligand complexes (14). The cells were then rapidly washed, and the reappearance of intact and degraded Tf in the medium was monitored by measuring TCA insoluble and soluble radioactivity, respectively. As expected, apo-Tf released into the medium from cells expressing the wild-type TR was undegraded (Fig. 5), because TR-apo-Tf complexes are efficiently recycled back to the cell surface through sorting and recycling compartments (35, 37, 43, 44). Only about 2% of the counts were in the TCA soluble fraction after 2 h (TCA soluble counts). In contrast, ~16% of the 125I-labeled Tf released from cells expressing the IiCT Ala7-Ala8 chimera was degraded, implying that this percentage of chimeras traffics directly from the cell surface to the lysosomal compartment where they are degraded. Although this is less efficient degradation than the IiCT chimera (~32%), these results demonstrate that the surface-expressed IiCT Ala7-Ala8 chimera is also efficiently delivered to the lysosomal compartment, albeit with reduced kinetics. This suggests three things. First, endocytosis does not appear to be the rate-limiting step in lysosomal transport of Ii. Second, only one of the cytoplasmic tail signals, either LI or ML, is necessary for efficient lysosomal delivery. Third, the two signals appear to be additive with regard to lysosomal targeting efficiency.


View larger version (17K):
[in this window]
[in a new window]
 
Fig. 5.   Degradation of Tf bound to Ii-TR chimeras. Equivalent cell numbers of CEFs expressing either wild-type TR, IiCT, or IiCT Ala7-Ala8 chimeras were preincubated in serum-free Dulbecco's modified Eagle's medium for 30 min at 37 °C and then incubated with 125I-labeled Tf for 1 h at 37 °C. The cells were then washed and reincubated at 37 °C in Dulbecco's modified Eagle's medium containing 50 µg/ml unlabeled Tf for various times. Acid-soluble radioactivity (open circle ) or acid-insoluble 125I-labeled Tf (triangle ) released into the medium, as well as surface-bound 125I-labeled Tf () and internalized 125I-labeled Tf (diamond ), were determined as described under "Experimental Procedures" and are expressed as a percentage of total radioactivity recovered. Each data point is the average of triplicate determinations from a representative experiment (of two).

The Membrane-distal Signal, DQRDLI, Is Necessary for Sorting at the TGN-- Because the majority of major histocompatibility complex class II complexes are delivered from the TGN to the lysosomal compartment without appearing on the cell surface, we tested to see whether the mutations that affected endocytosis also affected sorting at the TGN. Cells expressing wild-type TR, IiCT, IiCT Ala7-Ala8, IiCT Ala16-Ala17, IiCT Delta 20-29, IiCT Delta 20-24, and IiCT Delta 25-29 were incubated with 125I-labeled Tf for 1 h to label the endocytic pathway. The cells were then washed with BSA-PBS at 4 °C to remove the unbound Tf, lysed in 1% Nonidet P-40, and counted in a gamma counter. Comparison between the individual cell lines gave an estimate of the total amount of chimeras on the surface and in endosomal compartments (Table III, surface-labeled counts). In companion dishes, cells were pulsed-labeled with 35S-trans label for 30 min. TR or Ii-TR chimeras were then immunoprecipitated from postnuclear supernatants and quantitated on SDS-polyacrylamide gels by PhosphorImager analysis to determine the relative biosynthetic rates of each of the constructs. In a third set of dishes, we measured the relative half-lives of each of the constructs using a metabolic-pulse-chase procedure. The relative biosynthetic rates and degradation rates were then compared with the wild-type TR control. Based on the assumption that all the wild-type TR reaches the cell surface and is labeled with Tf, we estimate that only ~34% of the IiCT is delivered to the cell surface (surface-accessible pool; see under "Experimental Procedures" for details of the calculation) (Table III). The only mutation which increases the surface-accessible pool, is the Ala7-Ala8 mutation, the same one that disrupted endocytosis, suggesting that the signals for TGN sorting and endocytosis are closely related.

                              
View this table:
[in this window]
[in a new window]
 
Table III
Comparisons of the surface-accessible pools of Ii-TR chimeras, one of two independent experiments.

The Membrane-distal Sequence, DQRDLI, Can Substitute for the Membrane-proximal Signal without Affecting Endocytosis or Lysosomal Targeting-- The di-leucine signals in Ii appear to be related to the identified six-residue signal in the CD3 gamma -chain, DKQTLL (19). To test whether the two Ii di-leucine related sequences, DQRDLI and EQLPML, coded for independent structural motifs, such as those that have been identified for tyrosine-based signals (25-28, 45), we replaced one sequence, EQLPML, with the other, DQRDLI (IiCT 12DQRDLI17). We also prepared a mutant in which the two sequences were substituted for each other (IiCT 3EQLPML8, 12DQRDLI17, Fig. 1B).

Analysis of these two mutants in internalization assays indicated that IiCT 12DQRDLI17 and IiCT 3EQLPML8, 12DQRDLI17 were both endocytosed (Table I, ke = 0.077 and 0.050, respectively), although neither was equivalent to the wild-type Ii (Table I, ke = 0.117). Analysis of the IiCT 12DQRDLI17 mutant in a metabolic pulse-chase experiment indicated that it was rapidly degraded (t1/2 ~ 3 h, Fig. 6A). Whereas the IiCT 3EQLPML8, 12DQRDLI17 mutant had an extended half-life (t1/2 > 12 h, Fig. 6A). These results demonstrated that the DQRDLI sequence can substitute for the EQLPML signal without a significant loss of either sorting event, whereas swapping the two sequences results in a partial loss of internalization activity and an almost total loss of lysosomal targeting. This suggests that the sequence EQLPML could not substitute for the DQRDLI signal.


View larger version (52K):
[in this window]
[in a new window]
 
Fig. 6.   Structural requirements of the invariant chain cytoplasmic tail necessary for lysosomal targeting. Wild-type TR, IiCT 12DQRDLI17, or IiCT 3EQLPML8, 12DQRDLI17 (A) or wild-type TR, IiCT Delta 9, IiCT Delta 9-10, or IiCT Delta 9-11 (B) chimeras were pulse-chased, immunoprecipitated from postnuclear supernatants, and analyzed on SDS-polyacrylamide gels as described in Fig. 2. A representative experiment (of three) is shown.

Deletion of Ser9 (Delta 9), Ser9-Asn10 (Delta 9-10), or Ser9-Asn10-Asn11 (Delta 9-11) Inhibits Endocytosis without affecting Lysosomal Targeting-- To determine whether residues between the two di-leucine signals were required for either targeting event, we prepared mutants in which one, two, or three residues were deleted (IiCT Delta 9, IiCT Delta 9-10, and IiCT Delta 9-11, respectively; Fig. 1B). Analysis of these mutants indicates that these deletions result in a 32, 52, and 36% loss of internalization activity, respectively (Table I, ke = 0.079, 0.061, and 0.075, respectively). Analysis in metabolic pulse-chase experiments indicated that the half-lives remain unchanged (Fig. 6B; IiCTDelta 9, t1/2 ~ 3.0 h, IiCTDelta 9-10, t1/2 = 2.8 h, and IiCTDelta 9-11, t1/2 ~ 3.5 h, suggesting that these modifications affected endocytosis without corresponding effects on lysosomal targeting).

Two 10-Amino Acid Regions from the Ii Transmembrane Are Sufficient to Promote Lysosomal Targeting of the TR-- To localize the lysosomal targeting signal in the Ii TM domain (14), we prepared Ii-TR chimeras that contained ~10 amino acid segments from the Ii TM region transplanted into the corresponding regions of the wild-type TR (Fig. 7). Each of these chimeras was expressed in CEFs using BH-RCAS. Binding studies at 4 °C using 125I-labeled human Tf indicated that all of the chimeras were expressed on the cell surface of transfected CEFs, but at lower levels than the wild-type TR (data not shown).


View larger version (13K):
[in this window]
[in a new window]
 
Fig. 7.   Schematic diagram of the invariant chain-transferrin receptor transmembrane chimeras. Schematic representation of the transferrin receptor with various regions replaced by the corresponding sequence from the invariant chain. Unshaded areas represent regions of Ii-TR derived from TR; shaded areas represent regions derived from Ii. The sequence shown is the invariant chain transmembrane sequence. Residues 1-10, 11-19, and 20-29 of the transferrin receptor were replaced with the corresponding sequences from the invariant chain. Constructs are referred to in text by the corresponding names shown at the left.

Analysis of the chimeras in metabolic pulse-chase experiments indicated that two regions within the Ii TM region were sufficient to target the TR to a processing compartment, residues 11 though 19 and residues 20 though 29 (Fig. 8; IiTM 11-19, t1/2 ~ 3.0 h; IiTM 20-29, t1/2 ~ 3.5 h). For comparison, the half-lives of the wild-type TR and IiTM 1-10 chimera were 24 and 17 h, respectively. The chimera that contained Ii TM residues 1-10 and 20-29 had an average half-life of 2.5 h (Table II), suggesting that the TM 20-29 mutation was sufficient in either context for lysosomal targeting. As before, the Ii-TR chimeras were maturely glycosylated, indicating that they had traversed the Golgi complex and were not simply misfolded proteins. To confirm that proteolysis of the transmembrane chimeras was occurring in a lysosomal compartment, we determined their half-lives in the presence of ammonium chloride. The results indicate that the half-life of the IiTM 20-29 chimera was extended from 1.5 h to approximately ~8 h (Fig. 9), indicating that the degradation was occurring within the endocytic pathway. Ammonium chloride treatment extended the half-life of the IiTM 11-19 chimera as well (data not shown). A summary of the half-lives of the Ii-TR chimeras is shown in Table II. Analysis of the TM chimeras in internalization assays demonstrated that none of the mutations dramatically affected internalization (Table IV, 86-129% activities), indicating that the increased degradation of the chimeras was not caused by a corresponding increase in internalization.


View larger version (59K):
[in this window]
[in a new window]
 
Fig. 8.   Residues 11-19 and 20-29 of the invariant chain transmembrane region are sufficient to mediate targeting of the TR to a post-Golgi processing compartment. Equivalent cell numbers of CEFs expressing the WT TR, IiTM 1-10, IiTM 11-19, or IiTM 20-29 chimeras were pulse-chased, immunoprecipitated from postnuclear supernatants, and analyzed on SDS-polyacrylamide gels as described in Fig. 2. A representative experiment (of three) is shown.


View larger version (30K):
[in this window]
[in a new window]
 
Fig. 9.   Ammonium chloride inhibits degradation of the IiTM 20-29 chimera. CEFs expressing the IiTM 20-29 chimera were preincubated for 1 h at 37 °C in medium (control) or medium plus 50 mM NH4Cl (+50 mM NH4Cl) and then pulse-labeled with 35S-trans label and chased in the presence (+50 mM NH4Cl) or absence (control) of NH4Cl. The chimeras were then immunoprecipitated and analyzed on SDS-polyacrylamide gels as described in Fig. 2. A representative experiment (of two) is shown.

                              
View this table:
[in this window]
[in a new window]
 
Table IV
Comparisons of the internalization rates of the transferrin receptor-invariant chain transmembrane chimeras

    DISCUSSION
Top
Abstract
Introduction
Procedures
Results
Discussion
References

By analyzing Ii-TR chimeras in quantitative assays, we report that the two cytoplasmic tail di-leucine signals appear to be recognized at distinct cellular sites. We provide evidence that the membrane-distal signal, which includes Leu7-Ile8, is important for endocytosis and lysosomal targeting, whereas the membrane-proximal signal, which includes Met16-Leu17, appears to be important for lysosomal targeting (Fig. 10). The distinction between the two signals is best illustrated by the fact that modification of the membrane-distal signal, Leu7-Ile8 to Ala7-Ala8, resulted in a 9-fold reduction in internalization activity, whereas modification of the membrane-proximal signal, Met16-Leu17 to Ala16-Ala17, had less than a 2-fold effect. Interestingly, Leu7-Ile8 signal also appeared to be required for sorting at the TGN because its disruption resulted in a 3-fold increase in the amount of chimera that reached the cell surface. In contrast to sorting at the TGN and plasma membrane, both di-leucine signals appear to promote lysosomal targeting, although neither alone was as efficient as both in combination.


View larger version (7K):
[in this window]
[in a new window]
 
Fig. 10.   Summary of the structural features of the internalization and lysosomal targeting signals within the Ii cytoplasmic tail and transmembrane region. The cytoplasmic tail of Ii contains one region that is necessary for efficient endocytosis (overlined) and two regions that are required for efficient lysosomal targeting (underlined). Mutation of either region decreases lysosomal targeting efficiency by approximately 50%. Deletions between the two regions inhibit endocytosis (up to 50%) without affecting lysosomal targeting. The sequence DQRDLI can replace EQLPML without a significant loss of internalization or lysosomal targeting activity. The position of the two regions relative to the TM region influences both internalization and lysosomal targeting. Two regions within the Ii transmembrane domain are important for lysosomal targeting (underlined). Each TM region is individually sufficient to promote lysosomal of the TR. Neither TM region has any effect on endocytosis.

Met16-Leu17 has been reported to be important for internalization (14, 18, 21, 40, 46), but these studies were based on bivalent antibody binding or measurement of steady-state distributions. Bivalent antibodies have been shown to promote lysosomal targeting of receptors that normally recycle (47-51), including the TR (37, 43). In the present study, we directly measured transferrin uptake, a process that does not affect the endocytosis or trafficking of the TR (52). This allowed us to differentiate internalization signals from lysosomal signals because we followed the fate of the chimeras with a monovalent ligand (53), transferrin. Furthermore, because steady-state distribution measurements for estimation of internalization rates are based on the assumption that all of the cell surface protein efficiently recycles (14) (a requirement that is not met with lysosomally directed proteins, as is the case here), we measured the internalization rates directly.

One surprising finding regarding lysosomal targeting was the fact that although the IiCT Ala7-Ala8 chimera was poorly internalized, it was still rapidly degraded. The half-life of this chimera was the same as the IiCT Ala16-Ala17 chimera, which was internalized rapidly. This suggests that the rate-limiting step for lysosomal targeting is not endocytosis. Further support for this idea comes from studies on mutant hemagglutinins by Zwart et al. (54), who demonstrated that targeting to the latter stages of endocytic pathway does not simply correlate with the concentration of mutant hemagglutinins in the early endosome (54). With their hemagglutinin mutants, they demonstrated that there was no correlation between internalization rate and degradation rate and, furthermore, that the signal for these two processes were distinct. Although the IiCT Ala7-Ala8 chimera most dramatically illustrated the demarcation between these two processes, a number of the other Ii mutants (Delta 9, Delta 9-10, Delta 9-11) had compromised internalization activity without any lysosomal targeting loss. Studies on P-selectin and the epidermal growth factor receptor also support the idea that distinct regions of these two molecules are required for endocytosis and lysosomal targeting (55, 56). These studies, as well as our own on Ii, suggest, therefore, that monitoring endocytosis of cell surface molecules is not a reliable method for monitoring down-regulation or lysosomal targeting.

By monitoring the relative amounts of Ii-TR chimeras that reached the cell surface, we show that the same signal important for internalization, Leu7-Ile8, is also important for recognition at the TGN. A number of studies have suggested that di-leucine signals can be recognized at the cell surface (19, 57) and the TGN (20, 58). How recognition at the two cellular sites differs remains unclear. One attractive model is that the position of the signal within the tail specifies at which site it is recognized (59). Dietrich et al. (59) propose that receptors containing membrane-distal di-leucine signals are sorted directly from the TGN to the endosome/lysosome, whereas receptors containing membrane-proximal di-leucine signals require phosphorylation for internalization and lysosomal targeting. Consistent with this model, the Ii cytoplasmic tail is phosphorylated on a serine residue, although the site is not known (60). Although our study does not support this model because the membrane-distal signal appears to be required for sorting at both sites, it does support the idea that the position of the signal influences how and where it is recognized.

One of the goals of this study was to determine whether the two di-leucine signals in Ii were equivalent. Although position clearly influenced how each was being recognized, we also wondered whether the particular sequences themselves were specific. To address this point, we substituted the sequence from the membrane-distal signal, DQRDLI, for the membrane-proximal signal, EQLPML. Our results demonstrated that this mutation did not disrupt either targeting event, suggesting that there was nothing unique about the second signal. These results also suggested that di-leucine signals, like tyrosine-based signals, can often substitute for each other. Interestingly, however, swapping the signals resulted in a loss of both targeting events. The most likely explanation for this comes from the NMR data on a 27-residue peptide corresponding to the Ii cytoplasmic tail, which suggests that the first 14 residues lie within a nascent helix, whereas the membrane-proximal signal which includes Pro15-Met16-Leu17 is a part of a turn (22). Thus, placing a proline residue at position 6 of the Ii cytoplasmic tail probably disrupted the secondary structure, thereby inhibiting recognition for all sorting events.

Deletion of residues 20-29 of the Ii cytoplasmic tail indicated that none of these residues were specifically required for endocytosis or lysosomal targeting. The mutant lacking residues 20-29, however, was degraded more slowly than either of the two deletions encompassing this region, suggesting two things. First, none of the residues per se were required for lysosomal targeting; second, the position of the two di-leucine regions relative to the transmembrane region influenced lysosomal targeting. This is consistent with studies on LAMP-1 that suggest a strict positional requirement of a signal for lysosomal targeting signals (61). Interestingly, the membrane-proximal region of Ii has also been reported to be recognized by the basolateral sorting machinery in the biosynthetic pathway in MDCK cells (40). Our studies suggest that this region is not necessary for TGN recognition in fibroblasts because the relative amounts of this chimera that reached the cell surface were the same as the wild-type Ii (Table III).

Our analysis of the Ii transmembrane domain indicates that two 10-amino acid regions within this domain, residues 11-19 and residues 20-29, are sufficient to target the TR to lysosomal compartment without affecting the relative internalization rate. The structural features within these regions that mediate this effect are not known. We demonstrated that the chimeras were properly glycosylated, which suggests that none of them were misfolded proteins. We also showed that the degradation of the chimeras occurred within the endocytic pathway because it could be inhibited with weak bases. The only other known signals to be identified in transmembrane regions are Golgi retention signals (reviewed in Ref. 62). Interestingly, the important feature of Golgi localization signals appears to be the presence of uncharged polar residues (Asn, Thr, and Gln), which when mutated result in the loss of Golgi retention (63, 64). The Ii has an usual number of polar residues, although they are not lined along one face of the predicted helix as they are in the case of the cis-Golgi protein M (64). The implication from Golgi localization studies is that polar residues mediate protein-protein interactions resulting in oligomerization of protein complexes within the lipid bilayer (62). Oligomerization of the TM chimeras could result in a similar retention mechanism within the endocytic pathway, resulting in a loss of recycling efficiency.

Because the three-dimensional structure of the nonameric complex of the major histocompatibility complex class II molecule is not known, the significance of a signal within the transmembrane domain is not clear. However, because the interaction site between the alpha -beta chains and the Ii is in the extracellular domain and proteolysis of the Ii extracellular domain occurs first, one possibility is that the transmembrane signal operates once the extracellular portions of Ii are gone and the alpha -beta chains have been released. This would ensure that the residual portions of Ii would be degraded in the lysosome. Clearly, degradation of the Ii-TR chimera proceeds more rapidly when the Ii transmembrane region is included (14).

In conclusion, the results reported here suggest that the relative location of the di-leucine signal within the Ii cytoplasmic tail influences how it is recognized by the sorting machinery of the cell. Furthermore, our study suggests that TR chimeras containing Ii cytoplasmic tail or transmembrane signals are efficiently delivered to the lysosomal compartment. Because the cellular machinery required for sorting in the endosomal compartment has yet to be identified, it is unclear how signals from the two different domain structures would be recognized.

    ACKNOWLEDGEMENTS

We thank C. Wright for preparation of the CCL-1 construct and Christie Brouillette, Fred Maxfield, Doug Cyr, and Elizabeth Sztul for helpful discussions and for critical reading of the manuscript.

    FOOTNOTES

* Supported by NIDDK, National Institutes of Health, Grant R29-DK47339 and by grants from Sankyo Co., Ltd., and the Arthritis Foundation.The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

Dagger The first two authors contributed equally to this work.

§ To whom correspondence should be addressed: Department of Cell Biology, University of Alabama at Birmingham, BHSB 392, UAB Station, Birmingham, Alabama 35294-0005. Tel.: 205-934-1002; Fax: 205-934-0950; E-mail: jcollawn{at}uab.edu.

The abbreviations used are: Ii, human invariant chain; CEF, chicken embryo fibroblast; Tf, transferrin; TR, transferrin receptor; TM, transmembrane region; CT, cytoplasmic tail; IN, internalized; SUR, surface-associated; WT, wild-type.
    REFERENCES
Top
Abstract
Introduction
Procedures
Results
Discussion
References

  1. Peters, P. J., Neefjes, J. J., Oorschot, V., Ploegh, H. L., and Geuze, H. J. (1991) Nature 349, 669-676[CrossRef][Medline] [Order article via Infotrieve]
  2. Calafat, J., Nijenhuis, M., Janssen, H., Tulp, A., Dusseljee, S., Wubbolts, R., and Neefjes, J. (1994) J. Cell Biol. 126, 967-977[Abstract]
  3. Fernandez-Borja, M., Verwoerd, D., Sanderson, F., Aerts, H., Trowsdale, J., Tulp, A., and Neefjes, J. (1996) Int. Immunol. 8, 625-640[Abstract]
  4. Cresswell, P. (1994) Annu. Rev. Immunol. 12, 259-293[CrossRef][Medline] [Order article via Infotrieve]
  5. Blum, J. S., and Cresswell, P. (1988) Proc. Natl. Acad. Sci. U. S. A. 85, 3975-3979[Abstract]
  6. Lotteau, V., Teyton, L., Peleraux, A., Nilsson, T., Karlsson, L., Schmid, S. L., Quaranta, V., and Peterson, P. A. (1990) Nature 348, 600-605[CrossRef][Medline] [Order article via Infotrieve]
  7. Lamb, C. A., Yewdell, J. W., Bennick, J. R., and Cresswell, P. (1991) Proc. Natl. Acad. Sci. U. S. A. 88, 5998-6002[Abstract]
  8. Pieters, J., Horstmann, H., Bakke, O., Griffiths, G., and Lipp, J. (1991) J. Cell Biol. 115, 1213-1223[Abstract]
  9. Romagnoli, P., Layet, C., Yewdell, J., Bakke, O., and Germain, R. N. (1993) J. Exp. Med. 177, 583-596[Abstract]
  10. Newcomb, J. R., and Cresswell, P. (1993) J. Immunol. 151, 4153-4163[Abstract/Free Full Text]
  11. Benaroch, P., Yilla, M., Raposo, G., Ito, K., Miwa, K., Geuze, H. J., and Ploegh, H. L. (1995) EMBO J. 14, 37-49[Abstract]
  12. Wraight, C. J., van Endert, P., Moller, P., Lipp, J., Ling, N. R., MacLennan, I. C. M., Koch, N., and Moldenhauer, G. (1990) J. Biol. Chem. 265, 5787-5792[Abstract/Free Full Text]
  13. Roche, P. A., Teletski, C. L., Stang, E., Bakke, O., and Long, E. O. (1993) Proc. Natl. Acad. Sci. U. S. A. 90, 8581-8585[Abstract/Free Full Text]
  14. Odorizzi, C. G., Trowbridge, I. S., Xue, L., Hopkins, C. R., Davis, C. D., and Collawn, J. F. (1994) J. Cell Biol. 126, 317-330[Abstract]
  15. Swier, K., and Miller, J. (1995) J. Immunol. 155, 630-643[Abstract]
  16. Collawn, J. F., Stangel, M., Kuhn, L. A., Esekogwu, V., Jing, S., Trowbridge, I. S., and Tainer, J. A. (1990) Cell 63, 1061-1072[Medline] [Order article via Infotrieve]
  17. McGraw, T. E., and Maxfield, F. R. (1990) Cell Regul. 1, 369-377[Medline] [Order article via Infotrieve]
  18. Bremnes, B., Madsen, T., Gedde-Dahl, M., and Bakke, O. (1994) J. Cell Sci. 107, 2021-2032[Abstract/Free Full Text]
  19. Letourneur, F., and Klausner, R. D. (1992) Cell 69, 1143-1157[Medline] [Order article via Infotrieve]
  20. Johnson, K. F., and Kornfeld, S. (1992) J. Biol. Chem. 267, 17110-17115[Abstract/Free Full Text]
  21. Pond, L., Kuhn, L. A., Teyton, L., Schutze, M.-P., Tainer, J. A., Jackson, M. R., and Peterson, P. A. (1995) J. Biol. Chem. 270, 19989-19997[Abstract/Free Full Text]
  22. Motta, A., Bremnes, B., Morelli, M. A., Frank, R. W., Saviano, G., and Bakke, O. (1995) J. Biol. Chem. 270, 27165-27171[Abstract/Free Full Text]
  23. Bansal, A., and Gierasch, L. M. (1991) Cell 67, 1195-1201[Medline] [Order article via Infotrieve]
  24. Eberle, W., Sander, C., Klaus, W., Schmidt, B., von Figura, K., and Peters, C. (1991) Cell 67, 1203-1209[Medline] [Order article via Infotrieve]
  25. Pytowski, B., Judge, T. W., and McGraw, T. E. (1995) J. Biol. Chem. 270, 9067-9073[Abstract/Free Full Text]
  26. Collawn, J. F., Kuhn, L. A., Liu, L.-F. S., Tainer, J. A., and Trowbridge, I. S. (1991) EMBO J. 10, 3247-3253[Abstract]
  27. Jadot, M., Canfield, W. M., Gregory, W., and Kornfield, S. (1992) J. Biol. Chem. 267, 11069-11077[Abstract/Free Full Text]
  28. Johnson, A. O., Ghosh, R. N., Dunn, K. W., Garippa, R., Park, J., Mayor, J., Maxfield, F. R., and McGraw, T. E. (1996) J. Cell Biol. 135, 1749-1762[Abstract]
  29. Marks, M. S., Woodruff, L., Ohno, H., and Bonifacino, J. S. (1996) J. Cell Biol. 135, 341-354[Abstract]
  30. Arneson, L. S., and Miller, J. (1995) J. Cell Biol. 129, 1217-1228[Abstract]
  31. Kunkel, T. A. (1985) Proc. Natl. Acad. Sci. U. S. A. 82, 488-492[Abstract]
  32. Hughes, S. H., Greenhouse, J. J., Petropoulos, C. J., and Sutrave, P. (1987) J. Virol. 61, 3004-3012[Medline] [Order article via Infotrieve]
  33. Sanger, F., Nicklen, S., and Coulson, R. (1977) Proc. Natl. Acad. Sci. U. S. A. 74, 5463-5467[Abstract]
  34. Tabor, S., and Richardson, C. C. (1987) Biochemistry 84, 4767-4771
  35. Jing, S., Spencer, T., Miller, K., Hopkins, C., and Trowbridge, I. S. (1990) J. Cell Biol. 110, 283-294[Abstract]
  36. Wiley, H. S., and Cunningham, D. D. (1982) J. Biol. Chem. 257, 4222-4229[Free Full Text]
  37. Hopkins, C. R., and Trowbridge, I. S. (1983) J. Cell Biol. 97, 508-521[Abstract]
  38. Hughes, S. H., Petropoulos, C. J., Federspiel, M. J., Sutrave, P., Forrey-Schaudies, S., and Bradac, J. A. (1990) J. Reprod. Fertil. Suppl. 4, 39-49
  39. Bakke, O., and Dobberstein, B. (1990) Cell 63, 707-716[Medline] [Order article via Infotrieve]
  40. Odorizzi, G., and Trowbridge, I. S. (1997) J. Biol. Chem. 272, 11757-11762[Abstract/Free Full Text]
  41. Lamb, C. A., and Cresswell, P. (1992) J. Immunol. 148, 3478-3482[Abstract/Free Full Text]
  42. Omary, M. B., and Trowbridge, I. S. (1981) J. Biol. Chem. 256, 12888-12892[Abstract/Free Full Text]
  43. Weissman, A. M., Klausner, R. D., Rao, K., and Harford, J. B. (1986) J. Cell Biol. 102, 951-958[Abstract]
  44. Dunn, K. W., McGraw, T. E., and Maxfield, F. R. (1989) J. Cell Biol. 109, 3303-3314[Abstract]
  45. Collawn, J. F., Lai, A., Domingo, D., Fitch, M., Hatton, S., and Trowbridge, I. S. (1993) J. Biol. Chem. 268, 21686-21692[Abstract/Free Full Text]
  46. Simonsen, A., Stang, E., Bremnes, B., Roe, M., Prydz, K., and Bakke, O. (1997) J. Cell Sci. 110, 597-609[Abstract/Free Full Text]
  47. Anderson, R. G. W., Brown, M. S., Beisiegel, U., and Goldstein, J. L. (1982) J. Cell Biol. 93, 523-531[Medline] [Order article via Infotrieve]
  48. Mellman, I., Plutner, H., and Ukkonen, P. (1984) J. Cell Biol. 98, 1163-1169[Abstract]
  49. Mellman, I., and Plutner, H. (1984) J. Cell Biol. 98, 1170-1177[Abstract]
  50. Ukkonen, P., Lewis, V., Marsh, M., Helenius, A., and Mellman, I. (1986) J. Exp. Med. 163, 952-971[Abstract]
  51. Schwartz, A. L., Ciechanover, A., Merritt, S., and Turkewitz, A. (1986) J. Biol. Chem. 261, 15225-15232[Abstract/Free Full Text]
  52. Watts, C. (1985) J. Cell Biol. 100, 633-637[Abstract]
  53. Linderman, J. J., and Lauffenburger, D. A. (1988) J. Theor. Biol. 132, 203-247[Medline] [Order article via Infotrieve]
  54. Zwart, D. E., Brewer, C. B., Lazarovits, J., Henis, Y. I., and Roth, M. G. (1996) J. Biol. Chem. 271, 907-917[Abstract/Free Full Text]
  55. Green, S. A., Setiadi, H., McEver, R. P., and Kelly, R. B. (1994) J. Cell Biol. 124, 435-448[Abstract]
  56. Opresko, L. K., Chang, C.-P., Will, B. H., Burke, P. M., Gill, G. N., and Wiley, H. S. (1995) J. Biol. Chem. 270, 4325-4333[Abstract/Free Full Text]
  57. Ogata, S., and Fukuda, M. (1994) J. Biol. Chem. 269, 5210-5217[Abstract/Free Full Text]
  58. Chen, H. J., Remmler, J., Delaney, J. C., Messner, D. J., and Lobel, P. (1993) J. Biol. Chem. 268, 22338-22346[Abstract/Free Full Text]
  59. Dietrich, J., Hou, X., Wegener, A.-M. K., and Geisler, C. (1994) EMBO J. 13, 2156-2166[Abstract]
  60. Spiro, R. C., and Quaranta, V. (1989) J. Immunol. 143, 2589-2594[Abstract/Free Full Text]
  61. Rohrer, J., Schweizer, A., Russell, D., and Kornfeld, S. (1996) J. Cell Biol. 132, 565-576[Abstract]
  62. Machamer, C. E. (1993) Curr. Opin. Cell Biol. 5, 606-612[Medline] [Order article via Infotrieve]
  63. Swift, A. M., and Machamer, C. E. (1991) J. Cell Biol. 115, 19-30[Abstract]
  64. Machamer, C. E., Grim, M. G., Esquela, A., Chung, S. W., Rolls, M., Ryan, K., and Swift, A. M. (1993) Mol. Biol. Cell 4, 695-704[Abstract]


Copyright © 1998 by The American Society for Biochemistry and Molecular Biology, Inc.